Investor relations.
Five briefing materials, three operating principles. Doctrine evidence is public; financial and partner-name detail is the narrow envelope NDAs cover.
Funding to date.
Seed stage — KRW 300M raised in medical-sector capital on a profitable operating base.
- KRW 100MSeed
Medical-Industry ESG Personal Investment Association No. 1 — convertible bond (0% coupon, conversion price KRW 2,000, maturity Dec 2028).
- KRW 200MSeed
Physician Professional Investment Association No. 1.
- KRW 300MTotal
KRW 300M raised at seed stage — all capital sourced from medical-sector funds. An external signal that our spray sterilisation and decontamination is recognised by clinicians and medical institutions.
※ As of June 2026 · seed stage.
Briefing materials.
- 01Public
Capability pack
20-page PDFThree-pillar capability summary, doctrine references, validation evidence, and the 50-theater Lattice catalog reach claim laid out in one place.
Quarterly refresh - 02Public
Executive briefing deck
12-slide deckBD-package outline rendered for investor review — same artefact our partner BD teams receive, scrubbed of partner-specific scenarios.
Per-meeting refresh - 03Public
Validation pack
PDF + sample payloads19/19 HTTP 200 replay walkthrough · CBRN-CADS 40-scenario validation · 9 reference Lattice payloads. Available open at /software/lattice-extensions/sample-payloads.
Updated on each commit - 04Under NDA
Financials brief
1-pageBurn rate, runway, capital plan. Single page deliberately — investor diligence should walk to the doctrine + catalog evidence, not to financial detail.
Quarterly - 05Under NDA
Partner pipeline brief
2-pageStatus of allied partner conversations, named contacts, NDA scope per partner. Necessarily limited disclosure.
Monthly
Three principles.
- 01
Doctrine evidence over forecast
Every claim we make to an investor sits on a doctrine reference, a commit hash, or a validation run. Forward-looking statements are tagged as such.
- 02
Open before NDA
Public materials carry the substance. NDA-only artefacts are limited to financial detail and partner-name disclosure.
- 03
One signature
Investor materials are reviewed and signed by the founder, same hand as the editorial cadence and the catalog primitives.